Brit Insurance

Editor's comment: Commercially viable

The news that Iprism has secured private equity backing, which effectively values the business at £50m, is further evidence that the future of online commercial trading has finally reached its 'tipping point'.

Interview - Ray Cox: True Brit

Brit may have taken its time in naming a new UK CEO, but now Ray Cox is in place he tells Jonathan Swift he is eager to build on his forerunner's legacy.

Brit appoints new group CRO

Brit Insurance has appointed Baldeep Johal to the newly created position of group chief risk officer.

Fitch takes Brit off negative watch

Fitch Ratings has affirmed Brit Insurance Limited's Insurer Financial Strength rating at 'A', and Brit Insurance Holdings N.V.'s Long-term Issuer Default Rating at 'BBB+' and its subordinated notes at 'BB+.

Brit reports 8.5% drop in GWP

Brit Insurance has reported an 8.5% reduction in gross written premium to £1.22bn for the nine-month period ended 30 September 2010 (3Q 2009: £1.33bn), a decrease of 9.0% at constant exchange rates.

Brit reports 8.5% drop in GWP

Brit Insurance has reported an 8.5% reduction in gross written premium to £1.22bn for the nine-month period ended 30 September 2010 (3Q 2009: £1.33bn), a decrease of 9.0% at constant exchange rates.

Brit promotes Jonathan Mudd

Mr Mudd, North American professional indemnity underwriter in its global markets business, has been promoted to class underwriter and takes up this new role with immediate effect.

Editor's comment: Lloyd's soap rumbles on

As the clock ticked down to the Friday (15 October) deadline to complete a deal for Brit, the Dutch-domiciled insurer confirmed an extension has been granted to bidders Apollo and CVC Capital Partners.

Brit appoints new directors

Brit Insurance, has confirmed the appointment of four new board directors to its two main underwriting platforms: Brit Insurance Limited and Brit Syndicates Limited.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here